Managing secretions in dying patients.
Sorenson
H M
HM
Metropolitan Community College, Omaha, Nebraska 68111, USA. hsorenson@metropo.mccneb.edu
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000402:Airway Obstruction / Q000209:etiology* / Q000628:therapy*; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D005100:Expectorants / Q000627:therapeutic use; D006140:Guaifenesin / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D009079:Mucociliary Clearance / Q000187:drug effects; D009093:Mucus; D010166:Palliative Care / Q000379:methods*; D012138:Respiratory Therapy / Q000379:methods*; D013183:Sputum; D013256:Steroids; D013492:Suppuration; D013727:Terminal Care / Q000379:methods*; D014970:Xanthines / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D000701:Analgesics, Opioid; D000893:Anti-Inflammatory Agents; D005100:Expectorants; D006993:Hypnotics and Sedatives; D013256:Steroids; D014970:Xanthines; C008514:methylxanthine; D006140:Guaifenesin